ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OFIX vs SI // EV/EBITDA & P/E VALUATION

Orthofix Medical Inc. (NASDAQ) VS. Shoulder Innovations Inc. (NYSE) • 15-METRIC TALLY: OFIX 5 — SI 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFIX VS. SI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OFIX SI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.80% 76.50% -7.70 SI /gross-margins <GO>
Return on Invested Capital (ROIC) -12.20% -16.10% +3.90 OFIX /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 7.99% -8.46% +16.45 OFIX /fcf-yield <GO>
Operating Margin -9.90% -55.60% +45.70 OFIX /operating-margins <GO>
Net Profit Margin -11.20% -60.00% +48.80 OFIX /net-margins <GO>
Revenue Growth (YoY) 2.90% 49.60% -46.70 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.02 8.73 -7.71 SI /balance-sheet <GO>
Piotroski F-Score Quality 7/9 5/9 +2.00 OFIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.3 50.8 -8.53 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $417.1M $425.5M -$8.4M SI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OFIX REV SI REV OFIX GROSS % SI GROSS % OFIX FCF SI FCF
FY 2025 $822.3M $47.3M 68.8% 76.5% $33.3M -$36.0M
FY 2024 $799.5M $31.6M 68.3% 77.0% $25.8M -$18.2M
FY 2023 $746.6M — — — -$45.8M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFIX // BETA —
SI // BETA —